Kendra S. Carmon

2.8k total citations · 1 hit paper
40 papers, 2.1k citations indexed

About

Kendra S. Carmon is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kendra S. Carmon has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kendra S. Carmon's work include Wnt/β-catenin signaling in development and cancer (13 papers), Cancer Cells and Metastasis (9 papers) and HER2/EGFR in Cancer Research (9 papers). Kendra S. Carmon is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (13 papers), Cancer Cells and Metastasis (9 papers) and HER2/EGFR in Cancer Research (9 papers). Kendra S. Carmon collaborates with scholars based in United States, Bulgaria and Canada. Kendra S. Carmon's co-authors include Xing Gong, Anthony Thomas, Qingyun Liu, Qiushi Lin, David S. Loose, Jing Yi, Ali Azhdarinia, Ling Wu, Linda A. Luck and Ruth E. Baltus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Kendra S. Carmon

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling

2011 690 citations Kendra S. Carmon, Xing Gong et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Kendra S. Carmon

Since Specialization

Citations

This map shows the geographic impact of Kendra S. Carmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra S. Carmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra S. Carmon more than expected).

Fields of papers citing papers by Kendra S. Carmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendra S. Carmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra S. Carmon. The network helps show where Kendra S. Carmon may publish in the future.

Co-authorship network of co-authors of Kendra S. Carmon

This figure shows the co-authorship network connecting the top 25 collaborators of Kendra S. Carmon. A scholar is included among the top collaborators of Kendra S. Carmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra S. Carmon. Kendra S. Carmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models	Cell Reports Medicine	Zhengdong Liang, Yukimatsu Toh et al.	0
2	G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors	Cellular and Molecular Life Sciences	Brian J. Holleran, Charlotte Avet et al.	1
3	Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells	Molecular Cancer Therapeutics	Liezl E. Francisco, Zhengdong Liang et al.	10
4	G protein-coupled receptor-targeting antibody-drug conjugates: Current status and future directions	Cancer Letters	Kendra S. Carmon et al.	7
5	LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands	Scientific Reports	Yukimatsu Toh, Ling Wu et al.	9
6	GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism	Molecular Cancer Research	Sheng Zhang, Ling Wu et al.	39
7	The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis	Scientific Reports	Jianghua Tu, Soo-Hyun Park et al.	46
8	Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization	Cancer Research	Binghe Tan, Jie Zhang et al.	132
9	Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates	Molecular Pharmaceutics	Ali Azhdarinia, Sukhen C. Ghosh et al.	18
10	Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling	Journal of Biological Chemistry	Soo-Hyun Park, Jie Cui et al.	69
11	Synthesis of a Fluorescently Labeled ⁶⁸Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting	ACS Medicinal Chemistry Letters	Sukhen C. Ghosh, Melissa Rodríguez et al.	28
12	A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting	Journal of Nuclear Medicine	Sukhen C. Ghosh, Melissa Rodríguez et al.	9
13	LGR5 receptor promotes cell–cell adhesion in stem cells and colon cancer cells via the IQGAP1–Rac1 pathway	Journal of Biological Chemistry	Kendra S. Carmon, Xing Gong et al.	60
14	LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence	Molecular Cancer Therapeutics	Xing Gong, Ali Azhdarinia et al.	84
15	Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness	Oncogene	Jing Yi, Kendra S. Carmon et al.	59
16	LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor	PLoS ONE	Xing Gong, Kendra S. Carmon et al.	98
17	R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling breakdown →	Proceedings of the National Academy of Sciences	Kendra S. Carmon, Xing Gong et al.	690
18	Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors	Analytical Biochemistry	Kendra S. Carmon, David S. Loose	32
19	Wnt7a interaction with Fzd5 and detection of signaling activation using a split eGFP	Biochemical and Biophysical Research Communications	Kendra S. Carmon, David S. Loose	29
20	A biosensor for estrogenic substances using the quartz crystal microbalance	Analytical Biochemistry	Kendra S. Carmon, Ruth E. Baltus et al.	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact